Table 1.

Patient characteristics.

Number of Patients			571 (n)	100(%)
		Male	326	57.1
		Female	245	42.9
Median Age			72 years	63–80 IQRs
Median Age at diagnosis			66 years	56–74 IQRs
Median Follow-up			50.8 moths	24–97 IQRs
Patient died		Total number	125	21.8
		Male	73	58.4
		Female	52	41.6
Patient “Lost of Follow-up”		Documented	29	5.1
		Not documented	16	2.8
		Male	27	60
		Female	18	40
Initial Performance status		Documentation performed	534	93.5
		Normal activity	145	27.2
		Symptoms but fully ambulatory	248	46.4
		Symptoms but in Bed <50% of the day	46	8.6
		Needs to be in bed >50%of the day	12	2.2
		Unable to get out of bed	3	0.6
ECOG Score		Documentation performed	534	93.5
		ECOG 0–2	393	73.6
		ECOG 3–4	141	26.4
Weighted index of comorbidity		Documentation performed	332	58.1
	Estimated 10- year survival	points	Number	Percentage
	98–77 (%)	0–3 points	322	56.4
	53–0 (%)	4–6 points	10	1.8
Comorbidities			Number	Percentage
		Cardiovascular	26	4.5
		Dementia	4	0.7
		COPD	3	0.5
		Connective tissue disease	0	0
		Peptic ulcer	7	1.2
		Diabetes dellitus   Diabetes with end organ damage	30 2	5.2 0.35
		Moderate-severe denale disease	58	10.2
		Mild to severe liver disease	0	0
		Hemiplegia	0	0
		AIDS	0	0
		Any other malignancy within the last 5 years   Lymphoma   Leukaemia   Metastatic solid tumor	19 4 0 0	3.3 0.7 0 0
		Neuropathy	4	0.7
		Pain	34	5.9
CRAB		Documentation performed	431	75.5
		1 CRAB Criteria	313	72.6
		2 CRAB Criteria	65	15.1
		3 CRAB Criteria	40	9.3
		4 CRAB Criteria	13	3
R-ISS III		Documentation performed	522	91.4
		R-ISS III	109	19.1
Cytogenetics		High risk Intermediate/ standard risk Not documented	124 270 177	21.7 47.3 31
Type of multiple myeloma		Documentation performed	545	95.4
		IgG	304	55.8
		IgA	103	17.9
		Free Light Chain	134	23.3
		Other (Asecretory/IgD/E/M)	4	0.7